Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Perturbations in gut microbiota in autism spectrum disorder: a systematic review

Open access

Abstract

Background: Autism spectrum disorder (ASD) is a neurological and developmental disorder commonly accompanied by gut dysbiosis and gastrointestinal symptoms. Accumulating evidence supports a crucial role of gut microbiota dysbiosis in the pathophysiological mechanisms of ASD. However, the alteration of gut microbiota shows high heterogeneity across different studies. This study aims to identify potential biomarkers in the gut microbiota of patients with ASD. Methods: We conducted a comprehensive analysis by searching the PubMed, Web of Science, Cochrane Library, and Embase databases, for studies assessing the changes of gut microbial diversity and taxa in ASD patients and healthy controls using high-throughput sequencing. Vote counting analyses were performed to identify consistently altered gut microbes associated with ASD. Results: Sixty-four studies involving 189 differentially abundant gut microbial taxa were included. Our synthesis provided no strong evidence for a difference in α-diversity between ASD patients and healthy controls, while studies were relatively consistent in reporting differences in β-diversity. Among 189 taxa, we identified three significantly increased taxa in ASD patients: Eubacteriales, Klebsiella, and Clostridium. Additionally, there were enriched trends of Oscillospira, Dorea, and Collinsella, and depleted trends of Streptococcus, Akkermansia, Coprococcus, and Dialister. These findings suggest that the disrupted intestinal microecology and functional changes in ASD are characterized by an enrichment of pro-inflammatory genera, a reduction of specific probiotics, lactic acid-producing and utilizing bacteria, and an imbalance of anti-inflammatory butyrate-producing bacteria. Substantial heterogeneity across studies concerning demographics and methodologies was also observed. Conclusion: This systematic review contribute to a further understanding of the role of gut microbiota in ASD and support the development of microbiota-based diagnostic and therapeutic strategies for ASD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnins.2025.1448478

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 PRISMA flowchart.
FIGURE 1 PRISMA flowchart.CC BY · PubMed Central
FIGURE 2 Differences in α and β-diversity in patients with ASD compared to controls. (A) Differences in α-diversity between patients with ASD and controls. (B) Differences in β-diversity between patients with ASD and controls.
FIGURE 2 Differences in α and β-diversity in patients with ASD compared to controls. (A) Differences in α-diversity between patients with ASD and controls. (B) Differences in β-diversity between patients with ASD and controls.CC BY · PubMed Central
FIGURE 3 Differentially abundant taxa at the phylum (A), class (B), order (C), and family (D) levels in patients with ASD. Only the abundant taxa that were reported by ≥ 2 studies are shown. Each circle represents a taxon, and the size of each circle represents the number of studies that reported the taxa.
FIGURE 3 Differentially abundant taxa at the phylum (A), class (B), order (C), and family (D) levels in patients with ASD. Only the abundant taxa that were reported by ≥ 2 studies are shown. Each circle represents a taxon, and the size of each circle represents the number of studies that reported the taxa.CC BY · PubMed Central
FIGURE 4 Differentially abundant taxa at the genus (A–C) and species (D) levels in patients with ASD. Only the abundant taxa that were reported by ≥ 2 studies are shown. Each circle represents a taxon, and the size of each circle represents the number of studies that reported the taxa.
FIGURE 4 Differentially abundant taxa at the genus (A–C) and species (D) levels in patients with ASD. Only the abundant taxa that were reported by ≥ 2 studies are shown. Each circle represents a taxon, and the size of each circle represents the number of studies that reported the taxa.CC BY · PubMed Central
FIGURE 5 Vote counting statistics for differential microbial taxa that were reported by ≥ 3 studies at phylum (A), class (B), order (C), family (D), genus (E), species (F), no rank (G), and ratio (H) levels. An asterisk (*) represents the difference was statistically significant. The vote counting statistic for each taxon is represented by orange and blue bars. (I) Volcano plots of abundant taxa resulting from vote counting analyses. The x-axis indicates the vote counting statistic, and the y-axis shows the –log10 (P-value). The plot contains 107 gray dots (non-significant) and 3 red points (significantly up-regulated). Some gray points overlap due to identical vote counting statistic and P-values.
FIGURE 5 Vote counting statistics for differential microbial taxa that were reported by ≥ 3 studies at phylum (A), class (B), order (C), family (D), genus (E), species (F), no rank (G), and ratio (H) levels. An asterisk (*) represents the difference was statistically significant. The vote counting statistic for each taxon is represented by orange and blue bars. (I) Volcano plots of abundant taxa resulting from vote counting analyses. The x-axis indicates the vote counting statistic, and the y-axis shows the –log10 (P-value). The plot contains 107 gray dots (non-significant) and 3 red points (significantly up-regulated). Some gray points overlap due to identical vote counting statistic and P-values.CC BY · PubMed Central
FIGURE 6 Heatmap of abundant taxa at phylum (A), class (B), order (C), family (D), genus (E), and species, no rank and ratio (F) levels in the entire patient group and different subgroups of patients with ASD. Only taxa that were concordantly reported by ≥ 2 studies were presented here. Red represents that the taxon was consistently enriched, while blue represents that the taxon was consistently depleted across studies. An asterisk (*) represents the difference was statistically significant.
FIGURE 6 Heatmap of abundant taxa at phylum (A), class (B), order (C), family (D), genus (E), and species, no rank and ratio (F) levels in the entire patient group and different subgroups of patients with ASD. Only taxa that were concordantly reported by ≥ 2 studies were presented here. Red represents that the taxon was consistently enriched, while blue represents that the taxon was consistently depleted across studies. An asterisk (*) represents the difference was statistically significant.CC BY · PubMed Central
FIGURE 7 The alterations of gut microbiota and potential functional implications of bacterial genera implicated as different in ASD in this systematic review. These alterations are potentially related to the pathophysiology of ASD, as they involve the enrichment of pro-inflammatory genera, reduction of specific probiotics and lactic acid–producing bacteria, as well as the disturbance of butyrate-producing bacteria. Created with biogdp.com.
FIGURE 7 The alterations of gut microbiota and potential functional implications of bacterial genera implicated as different in ASD in this systematic review. These alterations are potentially related to the pathophysiology of ASD, as they involve the enrichment of pro-inflammatory genera, reduction of specific probiotics and lactic acid–producing bacteria, as well as the disturbance of butyrate-producing bacteria. Created with biogdp.com.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Research works printed but not linked: 1

  1. Wells, 2015, The Newcastle–Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses.

Cited by

See all 27

Metadata

Authors
Tao, X., Li, Z., Wang, D., Pu, J., Liu, Y., Gui, S., Zhong, X., Yang, D., Zhou, H., Tao, W., Chen, W., Chen, X., Chen, Y., Chen, X., & Xie, P.
Affiliations
The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
Corresponding author
Xie, Peng
Venue
Frontiers in Neuroscience
Published
2025-05-16
Volume
19
Pages
1448478-1448478
ISSN
1662-453X (ISSN-L)
OpenAlex
W4410453720
Cited by
23
References
50
Citations by year
2026: 20 · 2025: 3
FWCI
2.04
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Natural Science Foundation of Chongqing (cstc2022ycjh, CSTB2024NSCQ)
  • Centre Scientifique et Technique du Bâtiment
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
autism spectrum disorder, gut microbiota, dysbiosis, microbial biomarkers, gut dysbiosis, microbial diversity, pro-inflammatory bacteria, butyrate-producing bacteria, Akkermansia, Klebsiella, Clostridium, Oscillospira, Dorea, Collinsella, Streptococcus, lactic acid bacteria, gut-brain axis, microbiota-based therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Perturbations in gut microbiota in autism spectrum disorder: a systematic review. https://app.cochat.ai/papers/10.3389/fnins.2025.1448478
The paper
Tao, X., Li, Z., Wang, D., Pu, J., Liu, Y., Gui, S., Zhong, X., Yang, D., Zhou, H., Tao, W., Chen, W., Chen, X., Chen, Y., Chen, X., & Xie, P. (2025). Perturbations in gut microbiota in autism spectrum disorder: a systematic review. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2025.1448478

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.